#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Infantile spasms Choroid melanoma Neuroblastoma Hepatic cirrhosis Pneumonia Trigeminal neuralgia Obliterative bronchiolitis Neuropathy peripheral Sarcoidosis Vascular calcification Macular telangiectasia C3 glomerulopathy Neuromyelitis optica spectrum disorder Chronic myeloid leukaemia Hepatitis B More trials…

    Learn about Rare Diseases

    Marfan’s syndrome Extranodal marginal zone B-cell lymphoma (MALT type) – Diagnostics Cystic fibrosis – Basic Information Breast angiosarcoma metastatic – Diagnostics Hairy cell leukaemia – Life with Disease Osteosarcoma recurrent – Life with Disease Acute respiratory distress syndrome – Treatment Leiomyosarcoma metastatic – Life with Disease MELAS syndrome – Trials in Disease Pleural mesothelioma malignant – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Sonidegib Ertugliflozin TUVATEXIB Sodium Hypochlorite Serine Clopidogrel Meropenem Trihydrate Tipapkinogene Sovacivec Zoledronic Acid Monohydrate LYSERGIDE Estradiol Hemihydrate Larotrectinib Sulfate Pemetrexed GSKVX000000030918 Binimetinib Mitotane Atropine Sulfate Tas3351 Ep262 Golimumab More therapies…

    Learn about Your Condition

    Mite allergy Depression Prinzmetal angina Medulloblastoma recurrent Ventricular tachycardia Interstitial lung disease Dent's disease Alopecia areata Peripheral artery stenosis Triple negative breast cancer Haemoglobinuria Congenital myopathy T-cell type acute leukaemia Richter's syndrome Synovial sarcoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nervous System Diseases

  • Study on the Effectiveness and Safety of BHV-7000 for Adults with Refractory Focal Onset Epilepsy

    Not recruiting

    4 1
    Investigated Drugs:
    • Bhv-7000
    Denmark Finland Germany Greece Hungary Italy +5

  • Study of BMS-986446 for Early Alzheimer’s Disease Patients

    Not recruiting

    2 1
    Investigated Diseases:
    • Dementia Alzheimer’s type
    Investigated Drugs:
    • Prx005
    • Florquinitau (18F)
    Belgium Spain Sweden

  • Study on Basimglurant for Children, Adolescents, and Young Adults with Tuberous Sclerosis Complex-Related Seizures

    Not recruiting

    2 1
    Investigated Diseases:
    • Tuberous sclerosis complex
    Investigated Drugs:
    • Basimglurant
    Italy Poland Spain

  • Study on the Effectiveness of Tamsulosin for Treating Urinary Symptoms in Women with Multiple Sclerosis

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Multiple sclerosis
    Investigated Drugs:
    • Tamsulosin Hydrochloride
    France

  • Study on the Effects of Satralizumab for Patients with Autoimmune Encephalitis (NMDAR or LGI1)

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Encephalitis autoimmune
    Austria Czechia Denmark France Italy The Netherlands +2

  • Study on the Effects of Satralizumab in Children and Adolescents with Duchenne Muscular Dystrophy

    Not recruiting

    2 1 1
    Denmark Italy Poland Spain
Previous Page
1 … 101 102 103 104 105 … 142
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!